Refer A Patient

Request An Appointment

Gastroenterology

ENTYVIO

ENTYVIO (vedolizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Crohn’s disease & Ulcerative Colitis (UC)
Prescribed by Gastroenterologists
How it’s administered Intravenous (IV) infusion
Frequency Initial dose, then every two weeks for two doses, then six weeks later & then every eight weeks
Length of treatment 30 minutes to one hour

About This Therapy

ENTYVIO (vedolizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells that may cause inflammation. Specifically, it is an integrin receptor antagonist used in adults for the treatment of moderate to severely active Ulcerative Colitis (UC) and moderately to severely active Crohn’s disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

ENTYVIO REFERRAL FORM

ENTYVIO REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for ENTYVIO

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.